猪IGF2基因外显子3的遗传多态性及遗传效应分析

采用PCR-SSCP方法检测猪胰岛素样生长因子2 (insulin-like growth factor 2,IGF2)基因外显子3多态性,分析其对初生重、断奶重、6月龄重和背膘厚的遗传效应.根据猪IGF2基因的DNA序列（AY044828）设计引物,结果在其扩增片段上检测到多态性,对纯合子进行测序,发现IGF2-ex3-A36T和IGF2-ex3-G109A两个多态性位点,并且这2个多态性位点完全连锁,检测到3种基因型（A36A/G109G,A36T/G109A 和 T36T/A109A）.统计结果表明,基因型在各品种中分布不一致,长白猪和大白猪与莱芜猪、大薄莲猪、沂蒙黑猪和里岔黑猪比较基因型分布差异极显著（Ｐ<0.01）;其它猪种间基因型分布差异均不显著（Ｐ>0.05）.固定效应模型分析结果表明,初生重和背膘厚基因型间差异显著（Ｐ<0.05）,而断奶重和6月龄重基因型间差异不显著（Ｐ>0.05）.最小二乘分析结果表明,A36A/G109G基因型个体同A36T/G109A和 T36T/A109A基因型个体比较初生重和背膘厚的差异显著（Ｐ<0.05）,3种基因型初生重的大小排列顺序为A36A/G109G < A36T/G109A < T36T/A109A,背膘厚的大小排列顺序为A36A/G109G > A36T/G109A >T36T/A109A.因此,推测IGF2基因对个体的初生重和胴体瘦肉率存在一定的影响,将IGF2基因应用于猪育种过程中的标记辅助选择,将可以改善猪肉品质,加快猪的育种进程.     

Mitochondrially targeted anti-cancer agents

Cancer is an ever-increasing problem that is yet to be harnessed. Frequent mutations make this pathology very variable and, consequently, a considerable challenge. Intriguingly, mitochondria have recently emerged as novel targets for cancer therapy. A group of agents with anti-cancer activity that induce apoptosis by way of mitochondrial destabilisation, termed mitocans, have been a recent focus of research. Of these compounds, many are hydrophobic agents that associate with various sub-cellular organelles. Clearly, modification of such structures with mitochondria-targeting moieties, for example tagging them with lipophilic cations, would be expected to enhance their activity. This may be accomplished by the addition of triphenylphosphonium groups that direct such compounds to mitochondria, enhancing their activity. In this paper, we will review agents that possess anti-cancer activity by way of destabilising mitochondria and their possible targets. We propose that mitochondrial targeting, in particular where the agent associates directly with the target, results in more specific and efficient anti-cancer drugs of potential high clinical relevance.     

植物查尔酮合成酶超基因家族的分子进化

查尔酮合成酶(CHS)超基因家族又称为植物类型III聚酮合酶超基因家族, 其编码酶通过催化和合成一系列结构多样及生理活性各异的次生代谢物, 在植物生长发育和适应环境的过程中扮演着重要角色。为全面了解CHS超基因家族在植物中的进化规律, 重建其进化历史, 该研究利用14种具有全基因组数据的代表植物, 通过生物信息学手段, 深入挖掘和分析了不同植物类群基因组中查尔酮合成酶超基因家族的成员构成, 推测了其可能的扩增机制和功能分歧, 并探讨了该超基因家族在植物中的总体进化趋势。结果共识别144条具有表达信息的同源序列, 它们全部来自9种陆生植物的基因组, 藻类植物基因组中没有发现相关序列。系统发育和进化分析表明, CHS超基因家族的起源古老, 它们可能为适应复杂的生态环境而出现在早期的陆生植物中, 之后在长期的进化过程中不断发生谱系的特异扩张和拷贝丢失, 最后通过功能分歧的形式在不同植物类群中被分别固定。此外, 进化检验也显示, 尽管CHS超基因家族内部发生了多样的遗传改变, 但整个超基因家族仍处于强烈的纯化选择之下, 并且个体基因中也无任何单氨基酸位点受到正向选择的影响。     

两个单点突变对昆虫羧酸酯酶降解马拉硫磷的影响

马拉硫磷是一种高效低毒的有机磷杀虫剂, 分子量大且结构特殊, 广泛用于农业害虫的防治。羧酸酯酶突变是昆虫对有机磷类杀虫剂产生代谢抗性的重要机制之一。本实验室前期已从棉蚜Aphis gossypii、 褐飞虱Nilaparvata lugens、 斜纹夜蛾Spodoptera litura、 家蚕Bombyx mori、 异色瓢虫Harmonia axyridis、 赤拟谷盗Tribolium castaneum和西方蜜蜂Apis mellifera中各克隆了一个非特异性羧酸酯酶基因, 通过体外定点突变构建了G/A151D和W271L两种突变体, 并进行了原核细胞表达和纯化。本实验在体外测定了这7种昆虫野生型和两种突变型羧酸酯酶对马拉硫磷的降解。结果显示： 棉蚜、 西方蜜蜂、 斜纹夜蛾、 赤拟谷盗的野生型羧酸酯酶能够降解马拉硫磷, 两个突变并不能提高它们的降解活性, 而家蚕、 异色瓢虫和褐飞虱的野生型羧酸酯酶不能降解马拉硫磷, G/A151D和/或W271L突变能使这些酯酶获得马拉硫磷羧酸酯酶（MCE）的活性, 有可能使这些昆虫对马拉硫磷产生抗性。不同物种的MCE活性相差较大, 斜纹夜蛾的MCE活性最高, 其k_cat/K_m值为1.8~1.9 L/μmol·min, 其次是赤拟谷盗, 其K_cat/K_m值为0.87~0.95 L/μmol·min, 其他昆虫的MCE活性相对较低, 相差可高达10倍。     

猪IGF2基因的遗传多态性及其遗传效应分析

采用PCR-SSCP方法检测胰岛素样生长因子2 (insulin-like growth factor 2, IGF2)基因外显子7, 8, 9的多态性, 并分析其对初生重、断奶重、6月龄重和6月龄背膘厚的遗传效应。根据猪IGF2基因的DNA序列(AY044828)设计3对引物, 结果在Ex8引物对扩增的片段上发现了多态性, 并对纯合子进行测序, 发现exon8的53位存在C→T转换, 且检测到3种基因型(AA、AB、BB)。统计结果表明, 3种基因型在各品种中的分布不一致, 长白猪与大白猪比较, 莱芜猪与大薄莲猪比较, 沂蒙黑猪和里岔黑猪比较差异不显著(P > 0.05); 其他猪种间基因型分布的差异均显著(P < 0.01)。固定效应模型分析结果表明, 初生重和6月龄背膘厚基因型间差异显著(P < 0.05), 而断奶重和6月龄重基因型间差异不显著(P > 0.05)。最小二乘分析结果表明, BB基因型个体同AA和AB基因型个体比较初生重的差异显著(P < 0.05), 3种基因型在初生重的大小排列顺序为AB > AA > BB; AA基因型个体同AB和BB基因型个体比较6月龄背膘厚的差异显著(P < 0.05), 3种基因型在6月龄背膘厚的大小排列顺序为BB > AB > AA。因此, 推测IGF2基因对个体的初生重和胴体瘦肉率存在一定的影响, 将IGF2基因应用于猪育种过程中的标记辅助选择可以加快猪的育种进程。     

茎尖嫁接脱除柑橘黄龙病病原及其检测方法比较

运用茎尖微芽嫁接技术脱除柑橘黄龙病病原,并采用PCR技术和直接荧光法对脱毒后的植株进行脱毒效率检测。结果表明,茎尖微芽嫁接成活率最高为75%;茎尖微芽嫁接技术是脱除黄龙病病原的一种有效方法,脱毒率达100%,脱毒后均检测不到病原存在;PCR技术检测病毒的检出率为100%,而直接荧光法的检出率仅为33.3%,说明PCR技术具有更高的灵敏度。     

植物基因表达的代谢调控

通过分析代谢物、激素和环境因素对植物几种基因表达的影响,就植物基因表达的代谢调控进行了讨论,提出了开展有关这方面研究的一些设想。     

Determination of trace amino acids in human serum by a selective and sensitive pre-column derivatization method using HPLC-FLD-MS/MS and derivatization optimization by response surface methodology

Analysis of trace amino acids (AA) in physiological fluids has received more attention, because the analysis of these compounds could provide fundamental and important information for medical, biological, and clinical researches. More accurate method for the determination of those compounds is highly desirable and valuable. In the present study, we developed a selective and sensitive method for trace AA determination in biological samples using 2-[2-(7H-dibenzo [a,g]carbazol-7-yl)-ethoxy] ethyl chloroformate (DBCEC) as labeling reagent by HPLC-FLD-MS/MS. Response surface methodology (RSM) was first employed to optimize the derivatization reaction between DBCEC and AA. Compared with traditional single-factor design, RSM was capable of lessening laborious, time and reagents consumption. The complete derivatization can be achieved within 6.3 min at room temperature. In conjunction with a gradient elution, a baseline resolution of 20 AA containing acidic, neutral, and basic AA was achieved on a reversed-phase Hypersil BDS C₁₈ column. This method showed excellent reproducibility and correlation coefficient, and offered the exciting detection limits of 0.19–1.17 fmol/μL. The developed method was successfully applied to determinate AA in human serum. The sensitive and prognostic index of serum AA for liver diseases has also been discussed.     

Tetramethylrhodamine is an essential scaffold of azide probe in detecting cellular acrolein

Tetramethylrhodamine (TAMRA)-phenyl azide is a chemical probe used to detect intracellular acrolein directly in live cells. Herein, we demonstrated that TAMRA is the optimum fluorophore for the probe. TAMRA-phenyl azide was used to reveal that high levels of acrolein are generated in a variety of breast cancer cells, regardless of the tumor subtype. These findings corroborate the analysis presented in our previous report, in which TAMRA-phenyl azide was used to label breast cancer tissues resected from breast cancer patients. Because high levels of acrolein were generated in all cancer cell types, we believe that acrolein detection may be useful as a general method for labeling cancerous tissues.